Standard Biotools | FLDM - Gross Profit On Sales


Standard Biotools reported $9.48M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Agilent USD 990M 102M Sep/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Bio-Rad Laboratories USD 345.3M 34.7M Jun/2025
Bruker USD 379.4M 21.5M Sep/2025
Danaher USD 3.97B 443M Dec/2025
Illumina USD 759M 26M Dec/2025
Myriad Genetics USD 143.8M 8M Sep/2025
Nikon Corporation JPY 67.21B 14.78B Jun/2025
Revvity USD 374.6M 17.95M Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sony JPY 1.01T 160.99B Sep/2025
Standard Biotools USD 9.48M 1.15M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Waters USD 459.99M 21.97M Sep/2025